What is the Return on Assets (ROA) of Zomedica this year?
The Return on Assets (ROA) of Zomedica is -0.14 undefined this year.
Zomedica ROA 2024
Zomedica ROA
-0.14
Ticker
ZOM
ISIN
CA98980M1095
WKN
A2QEF3
In 2024, Zomedica's return on assets (ROA) was -0.14, a 124.1% increase from the -0.06 ROA in the previous year.
Zomedica Aktienanalyse
What does Zomedica do?
Zomedica Corp is an emerging company specializing in the development and marketing of innovative diagnostics and treatment options for pets. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan. Zomedica's business model is primarily focused on providing better diagnostics and therapy for pets to veterinarians and pet owners. The company develops and markets veterinary diagnostics and precise treatment solutions for various diseases in pets. Zomedica is divided into different divisions specializing in different areas of veterinary diagnostics and therapy. One of these divisions is "Point-of-Care" diagnostics, which allows veterinarians to perform quick and accurate diagnoses directly in their practice. Zomedica offers innovative devices and tests for the rapid diagnosis of diseases such as prostatitis or hypothyroidism. Another important division is "Companion Diagnostic" diagnostics, which is specifically focused on the diagnosis of cancer in pets. Zomedica has developed innovative tests that enable quick and precise diagnoses, allowing for targeted therapy initiation. In addition to diagnostics, Zomedica also offers innovative therapy solutions for pets. The company focuses on the development of antibiotics for animals, as well as precise treatment solutions for diseases such as diabetes or chronic kidney disease. One of Zomedica's best-known products is TRUFORMA, an innovative diagnostic device for veterinarians that enables quick and precise diagnosis of various diseases. The company has also developed a range of tests for the diagnosis of thyroid disease, prostatitis, and diabetes. In recent years, Zomedica has become one of the leading companies in veterinary diagnostics and therapy and has already convinced numerous veterinarians and pet owners of its innovative products and solutions. The company relies on close collaboration with veterinarians to continuously improve its products and tailor them to the needs of the market. Overall, Zomedica is an innovative company specializing in products and solutions for the needs of veterinarians and pet owners. With its innovative diagnostics and treatment solutions, the company is setting new standards in veterinary medicine and contributing to the improvement of pet health worldwide. Zomedica ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Zomedica's Return on Assets (ROA)
Zomedica's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Zomedica's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Zomedica's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Zomedica’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Zomedica stock
What was the ROA of Zomedica compared to the previous year?
The ROA of Zomedica has increased by 124.1% compared to the previous year.
What consequences do high ROA have for investors of Zomedica?
A high ROA is advantageous for investors of Zomedica, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Zomedica?
A low ROA can be unfavorable for investors of Zomedica as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Zomedica affect the company?
An increase in ROA of Zomedica can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Zomedica impact the company?
A reduction in the ROA of Zomedica can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Zomedica?
Some factors that can influence the ROA of Zomedica include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Zomedica important for investors?
The ROA of Zomedica is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Zomedica take to improve ROA?
To improve ROA, Zomedica can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Zomedica pay?
Over the past 12 months, Zomedica paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zomedica is expected to pay a dividend of 0 USD.
What is the dividend yield of Zomedica?
The current dividend yield of Zomedica is .
When does Zomedica pay dividends?
Zomedica pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zomedica?
Zomedica paid dividends every year for the past 0 years.
What is the dividend of Zomedica?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zomedica located?
Zomedica is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zomedica kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zomedica from 11/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.
When did Zomedica pay the last dividend?
The last dividend was paid out on 11/6/2024.
What was the dividend of Zomedica in the year 2023?
In the year 2023, Zomedica distributed 0 USD as dividends.
In which currency does Zomedica pay out the dividend?
The dividends of Zomedica are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zomedica
Our stock analysis for Zomedica Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zomedica Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
